Target intelligence / Profile preview

RNA, U4 small nuclear 31, pseudogene (RNU4-31P)

Target
RNU4-31P
Molecular classification
Other (Pseudogene, Non-coding RNA)
01

Overview

RNA, U4 small nuclear 31, pseudogene (RNU4-31P) is a non-protein-coding pseudogene, annotated as a member of the U4 small nuclear RNA pseudogenes, and does not code for a functional protein or RNA product involved in canonical spliceosomal or other biological roles[1][5]. There is no evidence this gene has any established biological function, disease role, or utility as a therapeutic target. No small molecules or drugs are known to interact with this locus, nor is it implicated as a biomarker or safety concern. The gene is listed in genome resources primarily as a locus annotation, and not as a functional or validated biological entity[1][5]. Analysis and Justification: - This entity is a pseudogene, not a canonical protein, enzyme, receptor, transporter, or even functional non-coding RNA[1][5]. - No known involvement in biological functions or disease, no validated protein/RNA product, and no druggability is described. - It is not considered a therapeutic target, and there is no common evidence of biomolecular or pharmaceutical relevance. - The name and abbreviation are correct and used in major databases[1][5]. - This entry could create confusion with functional U4 small nuclear RNAs (such as RNU4-2), which are genuine, essential spliceosomal RNAs and causal in disease when mutated[3][4][6][7]. However, RNU4-31P refers only to a pseudogene locus and is not itself implicated. - Therefore, is_incorrect is true as this target is not a functional drug target or relevant biomolecule, but merely a pseudogene genomic annotation. Summary: RNU4-31P represents a non-functional pseudogene with no clinical, mechanistic, or therapeutic significance. It should not be considered a drug or biomarker target, and is not implicated in any characterized biological or disease processes[1][5].

Other names
RNU4-31P

Beyond the preview

Go deeper on RNA, U4 small nuclear 31, pseudogene (RNU4-31P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 31, pseudogene (RNU4-31P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call